Insider plans sale of 171,750 shares on NASDAQ

An affiliated holder of AVAH common stock plans to sell 171,750 shares, with an aggregate market value of 1,361,978.00, through Morgan Stanley Smith Barney on the NASDAQ, with an approximate sale date of 02/19/2026.

Rhea-AI Filing Summary

An affiliated holder of AVAH common stock plans to sell 171,750 shares, with an aggregate market value of 1,361,978.00, through Morgan Stanley Smith Barney on the NASDAQ, with an approximate sale date of 02/19/2026.

The securities relate to restricted stock vesting on 02/14/2026, when 425,304 shares of common stock were acquired from the issuer. Over the prior three months, the same account sold 50,970 shares of common stock for gross proceeds of 413,942.66.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AVAH shares are planned for sale under this Form 144?

171,750 shares of AVAH common stock are planned for sale. The filing lists an aggregate market value of 1,361,978.00, with Morgan Stanley Smith Barney handling the transaction on NASDAQ and an approximate sale date of 02/19/2026.

What recent AVAH stock sale activity is disclosed in this Form 144?

The notice reports a prior sale of 50,970 shares of AVAH common stock. That transaction occurred on 01/02/2026 and generated gross proceeds of 413,942.66, providing context for recent selling activity from the same account over the past three months.

How were the AVAH shares being sold under Rule 144 originally acquired?

The shares were acquired through restricted stock vesting on 02/14/2026. On that date, the filer obtained 425,304 shares of AVAH common stock from the issuer, with the form describing the payment terms as “Not Applicable,” indicating no separate cash purchase price at vesting.

Which broker and exchange are involved in the planned AVAH share sale?

The filing lists Morgan Stanley Smith Barney LLC Executive Financial Services as broker. The planned sale of 171,750 AVAH common shares is to occur on the NASDAQ exchange, with Morgan Stanley’s New York office address provided in the disclosure.

What representation does the AVAH insider make about nonpublic information?

By signing the notice, the selling person represents they do not know any material adverse information about AVAH’s current or prospective operations that has not been publicly disclosed, as required in the standard Rule 144 Form 144 representation language included in the document.

What is the approximate timing of the AVAH stock sale under this notice?

The approximate date of sale for the 171,750 AVAH common shares is listed as 02/19/2026. This timing applies to the proposed NASDAQ transaction handled through Morgan Stanley Smith Barney, as disclosed in the securities information section of the notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 08:38 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001859462
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Aveanna Healthcare Holdings, Inc.
SEC File Number	001-40362
Address of Issuer	400 INTERSTATE NORTH PARKWAY STE 1700 ATLANTA GEORGIA 30339
Phone	770-441-1580
Name of Person for Whose Account the Securities are To Be Sold	Reisz Edwin C.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	171750	1361978.00	1321114	02/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/14/2026	Restricted Stock Vesting	Issuer			425304	02/14/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	Common Stock	01/02/2026	50970	413942.66

144: Remarks and Signature

Remarks	These shares will automatically be sold on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units on the date of the vesting event. The sale is mandated by the Reporting Person's adoption of a Rule 10b5-1 trading plan and does not represent a discretionary trade by the Reporting Person.
Date of Notice	02/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jonathan Beckler
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)